Hepatocellular caricinoma: Issues with Radioembolization
Hepatocellular carcinoma (HCC) is caused by liver cirrhosis, viral hepatitis (80% HBsAg positive, 10% anti-HCV positive), chronic liver disease, and afaltoxin B1. Small HCC is rarely seen, and abdominal pain with RUQ mass is the most common finding, with friction rub or bruit over liver, bloody ascites, and rarely jaundice. In addition, an anemia, leukocytosis, elevated levels of AFP / ALP / 5-nucleotidase, etc. can be confirmed by the test results. Abdominal ultrasonography (U / S) and α-fetoprotein are used as a screening test to diagnose hepatocellular carcinoma. Tumor markers such as α-FP and PIVKA Ⅱ are available. If abnormal findings are detected in the U / S, CT can be taken and MRI and PET-CT can be used for more accurate confirmation. Biopsy is not a frequent diagnostic method Radical therapy of hepatocellular carcinoma is performed at the early stage of diagnosis, including surgical resection, liver transplantation and local ablation therapy. Transarterial chemoembol...